It is a great pleasure to invite you to Georgian Ophthalmological Society & European Society of Ophthalmology “GOS/SOE 2016” joint meeting taking place in Tbilisi, Georgia, on June 10-12. Now GOS meetings have become traditional events held every second year for all ophthalmologists worldwide. The meeting will be extended on three consecutive days. It covers modern approaches and new frontiers in medical and surgical profiles in Ophthalmology.
Abstract: Sturge–Weber syndrome has been included in the group of phakomatoses that is characterized by hamartomas involving the brain, skin, and eyes. The characteristic facial port-wine stain, involving the first branch of the trigeminal nerve and the embryonic vasculature distribution in this area, leads to several ocular complications of the anterior segment and can involve the eyelids and conjunctiva. The posterior segment of the eyes is also affected with diffuse choroidal hemangiomas. However, the most frequent ocular comorbidity is glaucoma with a prevalence rate ranging from 30%–70%. Glaucoma is related to anterior chamber malformations, high episcleral venous pressure (EVP), and changes in ocular hemodynamics. Glaucoma can be diagnosed at birth, but the disease can also develop during childhood and in adults. The management of glaucoma in Sturge–Weber syndrome patients is particularly challenging because of early onset, frequently associated severe visual field impairment at the time of diagnosis, and unresponsiveness to standard treatment. Several surgical approaches have been proposed, but long-term prognosis for both intraocular pressure control and visual function remains unsatisfactory in these patients. Choroidal hemangiomas may also lead to visual impairment thorough exudative retinal detachment and macular edema. Treatment of exudative hemangioma complications is aimed at destructing the tumor or decreasing tumor leakage.
The Asia-Pacific Vitreo-retina Society (APVRS) serves as an excellent platform to address the emerging disease burden and create programs for developing skilled human resources. I welcome you to the 2016 APVRS Congress in Bangkok. It will be a perfect environment to teach and learn, to meet peers and friends, and most importantly, to identify the ways and means of supporting one of the developing countries in the region.
We live in an ever faster moving but smaller world due internet, digital innovations and social media. However acquiring knowledge is not complete without the live interactions of your teachers, colleagues and representatives of new technology. Once every two years the highlight of European ophthalmology is celebrated during the SOE Congress
PROLENSA (bromfenac ophthalmic solution) 0.07% is a nonsteroidal
anti-inflammatory drug (NSAID) indicated for the treatment of postoperative
inflammation and reduction of ocular pain in patients who have undergone
Background: Dry eye disease (DED), a chronic disorder affecting the tear film and lacrimal functional unit, is a widely prevalent condition associated with significant burden and unmet treatment needs. Since specific neural circuits play an important role in maintaining ocular surface health, microelectrical stimulation of these pathways could present a promising new approach to treating DED. This study evaluated the efficacy and safety of nasal electrical stimulation in patients with DED.
As usual, the IGR will provide you with high quality glaucoma content including the Comments in the Editor’s Selection, the Dialogue, Opinion, and news from the WGA, meeting reports, etc. With this new format, you will be able to quickly navigate the content online and obtain the information that is of interest. If desired, you also will be able to obtain more details via direct links (articles, abstracts, database, etc.).
Abstract: Adaptive optics (AO) retinal imaging has become very popular in the past few years, especially within the ophthalmic research community. Several different retinal techniques, such as fundus imaging cameras or optical coherence tomography systems, have been coupled with AO in order to produce impressive images showing individual cell mosaics over different layers of the in vivo human retina. The combination of AO with scanning laser ophthalmoscopy has been extensively used to generate impressive images of the human retina with unprecedented resolution, showing individual photoreceptor cells, retinal pigment epithelium cells, as well as microscopic capillary vessels, or the nerve fiber layer. Over the past few years, the technique has evolved to develop several different applications not only in the clinic but also in different animal models, thanks to technological developments in the field. These developments have specific applications to different fields of investigation, which are not limited to the study of retinal diseases but also to the understanding of the retinal function and vision science. This review is an attempt to summarize these developments in an understandable and brief manner in order to guide the reader into the possibilities that AO scanning laser ophthalmoscopy offers, as well as its limitations, which should be taken into account when planning on using it.
Сайт основан 20 декабря 2000 года
Авторские права на дизайн и всю информацию веб-сайта www.eyenews.ru (www.glaucomanews.ru www.corneanews.ru, www.cataractanews.ruwww.retinanews.ru www.айньюс.рф www.hrtclubrussia.ru), а также на подбор и расположение материалов принадлежат учредителю и редакции вышеуказаных порталов. Использование материалов сайтов разрешено только с письменного разрешения учредителя и редакции вышеуказанных сайтов. Воспроизведение фотографий, статей и новостей, абстрактов и прочего контента любым способом без письменного разрешения запрещено и влечет ответственность, предусмотренную законодательством о защите авторских прав. Запрещается автоматизированное извлечение информации сайта любыми сервисами без официального разрешения учредителя либо редакции сайтов. При цитировании материалов ссылка наwww.eyenews.ru и другие вышеуказанные сайты обязательна.